Iwasaki Y, Matsuura K, Tsuji T
First Department of Internal Medicine, Okayama University Medical School, Japan.
Gastroenterol Jpn. 1990 Aug;25(4):451-7. doi: 10.1007/BF02779333.
Polypeptides encoded by the pre-S1 and pre-S2 genes of hepatitis B virus (HBV) (pre-S1 antigen and pre-S2 antigen) were detected by enzyme-linked immunosorbent assay (ELISA) in 137 serum samples of patients with HBV infection. The HBV-DNA level closely correlated with the titer of pre-S antigens. However, HBV-DNA levels more closely correlated with the titer of the pre-S1 antigen [HBV-asymptomatic carrier (ASC): n = 40, r = 0.800, P less than 0.01; chronic hepatitis B (CH): n = 60, r = 0.730, P less than 0.01] than with the titer of the pre-S2 antigen [ASC: r = 0.675, P less than 0.01; CH: r = 0.575, P less than 0.01]. Thirty patients with CH, in whom hepatitis e antigen (HBeAg) was cleared after acute exacerbation (AE) [alanine aminotransferase (ALT) level greater than 200 IU/L] and the ALT level normalized, were followed for 12 months and classified into two groups: Group 1, those in whom HBeAg reappeared with an elevated ALT level within 12 months, and Group 2, those in whom HBeAg was persistently cleared from the serum and a normal ALT level continued. Of the 30 patients, 24 (80%) were classified into Group 1 and 6 (20%) were classified into Group 2. Changes in serum levels of HBV markers a month before and after AE were observed. The HBV-DNA level and DNA-P activity became negative after AE in both groups. The titer of pre-S1 antigen also decreased after AE, and no significant differences were observed between Group 1 and Group 2.(ABSTRACT TRUNCATED AT 250 WORDS)
采用酶联免疫吸附测定(ELISA)法检测了137例乙肝病毒(HBV)感染患者血清样本中由HBV前S1和前S2基因编码的多肽(前S1抗原和前S2抗原)。HBV-DNA水平与前S抗原滴度密切相关。然而,HBV-DNA水平与前S1抗原滴度的相关性更为密切[HBV无症状携带者(ASC):n = 40,r = 0.800,P<0.01;慢性乙型肝炎(CH):n = 60,r = 0.730,P<0.01],高于与前S2抗原滴度的相关性[ASC:r = 0.675,P<0.01;CH:r = 0.575,P<0.01]。对30例CH患者进行了12个月的随访,这些患者在急性加重期(AE)(丙氨酸转氨酶(ALT)水平>200 IU/L)后乙肝e抗原(HBeAg)清除且ALT水平恢复正常,之后将他们分为两组:第1组,在12个月内HBeAg随ALT水平升高而再次出现的患者;第2组,血清中HBeAg持续清除且ALT水平持续正常的患者。30例患者中,24例(80%)被归入第1组,6例(20%)被归入第2组。观察了AE前后1个月血清中HBV标志物水平的变化。两组患者在AE后HBV-DNA水平和DNA-P活性均转为阴性。AE后前S1抗原滴度也降低,第1组和第2组之间未观察到显著差异。(摘要截短于250词)